Status:
COMPLETED
Povidone Iodine Versus Normal Saline in Preoperative Vaginal Cleansing Before Caesarean Section
Lead Sponsor:
Federal Teaching Hospital Abakaliki
Conditions:
Povidone Iodine
Normal Saline
Eligibility:
FEMALE
15-45 years
Phase:
NA
Brief Summary
Post-caesarean maternal infectious morbidity is still a big challenge despite prophylactic antibiotics and preoperative vaginal cleansing with povidone-iodine use in reduction of post-caesarean endome...
Detailed Description
BACKGROUND: Maternal infectious morbidity is a common complication of caesarean section and is the third leading cause of maternal mortality in Nigeria and account for 15% of maternal death worldwide....
Eligibility Criteria
Inclusion
- . All consenting parturient for either elective or emergency caesarean section after the age of viability
Exclusion
- Women with known allergy to topical povidone-iodine.
- Women with presence of pre-existing vaginal irritation symptoms as itching, burning, swelling and vaginal pain.
- Antepartum haemorrhage (Placenta praevia).
- Cord prolapse
- Clinical evidence of Chorioamnionitis
- Face presentation with ruptured membranes to avoid contact of fetal face with iodine.
- Women with immunosupression due to HIV/AIDS, Diabetes Miletus or chronic use of steroids.
Key Trial Info
Start Date :
October 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 9 2021
Estimated Enrollment :
224 Patients enrolled
Trial Details
Trial ID
NCT06950229
Start Date
October 6 2020
End Date
March 9 2021
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alex Ekwueme Federal University Teaching Hospital
Abakaliki, Ebonyi State, Nigeria, 480101